Page breadcrumb nav

VAERS Report 2156870

Case Report Section

Détails du rapport Vaer

Âge: 30 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: unknown


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-02-10
Date d’apparition
7
Nombre de jours (date d’apparition – date de vaccination)
7
Description de l’événement indésirable

flu symptoms; menstrual cycle abnormal; this case was received via the regulatory authority ra (reference number: gb-mhra-adr 26633318) on 23-feb-2022 and was forwarded to moderna on 23-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of influenza (flu symptoms) and menstrual disorder (menstrual cycle abnormal) in a 30-year-old female patient who received mrna-1273 (moderna covid-19 vaccine) for an unknown indication. no medical history information was reported. on 10-feb-2022, the patient received third dose of mrna-1273 (moderna covid-19 vaccine) (unknown route) 1 dosage form. on 17-feb-2022, the patient experienced menstrual disorder (menstrual cycle abnormal) (seriousness criterion medically significant). on an unknown date, the patient experienced influenza (flu symptoms) (seriousness criterion medically significant). at the time of the report, influenza (flu symptoms) had resolved and menstrual disorder (menstrual cycle abnormal) had not resolved. diagnostic results (normal ranges are provided in parenthesis if available): on an unknown date, sars-cov-2 test: negative (negative) no - negative covid-19 test. the action taken with mrna-1273 (moderna covid-19 vaccine) (unknown) was unknown. concomitant medications were not provided. patient had a lot of soreness and flu symptoms immediately after booster, followed by menstruation 10 days earlier than expected. usually very regular 28 day cycle. patient has not had symptoms associated with covid-19 and was not tested positive for covid-19 since having the vaccine. patient was not pregnant and was not currently breastfeeding. patient was not enrolled in clinical trial. patient had no possible inflammation of the heart like myocarditis or pericarditis. treatment information was not provided. company comment: this is a regulatory authority case concerning a 30-year-old, female patient with no reported medical history, who experienced the unexpected serious (medically significant according to regulatory authority) events of flu symptoms and abnormal menstrual cycle. the event flu symptoms exact occurrence unknown but stated that it occurred immediately after the third dose of mrna-1273 vaccine administration accompanied by a lot of soreness while the event abnormal menstrual cycle occurred approximately 7 days after the third dose of mrna-1273 vaccine administration. the events were described as, patient experienced a lot of soreness and flu symptoms immediately after booster, followed by menstruation 10 days earlier than expected. the patient's menstrual cycle is usually very regular with 28-day cycle. no reported treatment information. the outcome of the event flu symptoms was resolved, abnormal menstrual cycle was not resolved from the time of last observation while a lot of soreness the outcome was unknown. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report.; sender's comments: this is a regulatory authority case concerning a 30-year-old, female patient with no reported medical history, who experienced the unexpected serious (medically significant according to regulatory authority) events of flu symptoms and abnormal menstrual cycle. the event flu symptoms exact occurrence unknown but stated that it occurred immediately after the third dose of mrna-1273 vaccine administration accompanied by a lot of soreness while the event abnormal menstrual cycle occurred approximately 7 days after the third dose of mrna-1273 vaccine administration. the events were described as, patient experienced a lot of soreness and flu symptoms immediately after booster, followed by menstruation 10 days earlier than expected. the patient's menstrual cycle is usually very regular with 28-day cycle. no reported treatment information. the outcome of the event flu symptoms was resolved, abnormal menstrual cycle was not resolved from the time of last observation while a lot of soreness the outcome was unknown. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report.

Données de laboratoire
test name: covid-19 virus test; test result: negative ; result unstructured data: no - negative covid-19 test
Liste des symptômes
menstrual disorder influenza sars-cov-2 test
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na